Sentinel node biopsy pioneer to obtain McGuire Award
December 09, 2025
1 min learn
Key takeaways:
- Armando E. Giuliano, MD, will obtain the 2025 William L. McGuire Memorial Lecture Award.
- Giuliano is being acknowledged for his work in axillary staging.
At this yr’s San Antonio Breast Most cancers Symposium, Armando E. Giuliano, MD, will obtain the William L. McGuire Memorial Lecture Award.
Giuliano will obtain the award, which acknowledges physicians who’ve made important contributions to the sphere of breast oncology, on the second day of the symposium.
He’s being acknowledged for pioneering sentinel lymph node biopsy approach for breast most cancers, a process that identifies and removes the lymph nodes the place most cancers is prone to unfold first.
Giuliano led the ACOSOG Z0010 and ACOSOG Z0011 trials, which validated that sentinel node biopsy was a secure different to axillary lymph node dissection — which can lead to surgical issues and lymphedema — in node-negative sufferers and sufferers with restricted sentinel node positivity.
At Cedars-Sinai Medical Middle, Giuliano is the Linda and Jim Lippman Chair in Surgical Oncology, chief of breast surgical oncology, regional medical director for Cedars-Sinai Most cancers breast oncology and affiliate director of the Samuel Oschin Complete Most cancers Institute. He is also codirector of the Saul and Joyce Brandman Breast Middle.
“It’s a nice honor to obtain the 2025 McGuire Award in recognition of my work in axillary staging,” Giuliano mentioned in a press launch. “Z0011 was a very tough research to do as a result of it challenged long-held medical dogma, however progress solely comes from asking arduous questions. Due to the devoted work of the workers at [the American College of Surgeons Oncology Group], the PIs at many establishments and the courageous sufferers who participated, Z0011 has helped us to de-escalate therapy and enhance the lives of sufferers with early metastatic breast most cancers.”
Ask a scientific query and faucet into Healio AI’s data base.
- PubMed, enrolling/recruiting trials, pointers
- Scientific Steering, Healio CME, FDA information
- Healio’s unique every day information protection of scientific knowledge
